Metastatic Biliary Tract Cancer

Also known as: Biliary cancer metastatic / Metastatic Biliary Cancer / Metastatic Biliary Cancers

DrugDrug NameDrug Description
DB11714DurvalumabAn antineoplastic monoclonal antibody used to treat urothelial carcinoma and locally advanced, unresectable non-small cell lung cancer.
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DrugDrug NamePhaseStatusCount
DB08885Aflibercept1Completed1
DB01101Capecitabine1Completed1
DB14776Camrelizumab1 / 2Not Yet Recruiting1
DB00515Cisplatin1 / 2Not Yet Recruiting1
DB00441Gemcitabine1 / 2Not Yet Recruiting1
DB14765Rivoceranib1 / 2Not Yet Recruiting1
DB17164ZB1311 / 2Completed1
DB00515Cisplatin2Completed1
DB00515Cisplatin2Terminated1
DB00544Fluorouracil2Completed1
DB00441Gemcitabine2Completed1
DB00441Gemcitabine2Terminated1
DB06186Ipilimumab2Completed1
DB00762Irinotecan2Completed2
DB00650Leucovorin2Completed2
DB09035Nivolumab2Completed1
DB00526Oxaliplatin2Completed1
DB00544FluorouracilNot AvailableRecruiting1
DB00762IrinotecanNot AvailableRecruiting1
DB00650LeucovorinNot AvailableRecruiting1